OTC Markets OTCPK - Delayed Quote USD

Raia Drogasil S.A. (RADLY)

Compare
4.1700 -0.7300 (-14.90%)
As of 10:01 AM EST. Market Open.
Currency in BRL All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
37,701,156.0000
33,973,790.0000
29,067,380.0000
24,127,002.0000
20,066,840.0000
Cost of Revenue
26,453,573.0000
23,766,426.0000
20,257,912.0000
16,920,834.0000
14,175,708.0000
Gross Profit
11,247,583.0000
10,207,364.0000
8,809,468.0000
7,206,168.0000
5,891,132.0000
Operating Expense
8,932,254.0000
8,254,020.0000
6,967,541.0000
5,831,670.0000
4,952,142.0000
Operating Income
2,315,329.0000
1,953,344.0000
1,841,927.0000
1,374,498.0000
938,990.0000
Net Non Operating Interest Income Expense
-972,537.0000
-916,576.0000
-673,914.0000
-388,723.0000
-304,939.0000
Pretax Income
1,431,996.0000
1,216,693.0000
1,193,209.0000
987,262.0000
616,368.0000
Tax Provision
292,836.0000
129,550.0000
178,241.0000
223,129.0000
120,835.0000
Net Income Common Stockholders
1,110,303.0000
1,054,973.0000
996,112.0000
751,934.0000
484,444.0000
Diluted NI Available to Com Stockholders
1,110,303.0000
1,054,973.0000
996,112.0000
751,934.0000
484,444.0000
Basic EPS
0.67
0.62
0.60
0.44
0.28
Diluted EPS
0.66
0.62
0.60
0.44
0.28
Basic Average Shares
1,665,715.2500
1,695,194.0000
1,647,653.0000
1,715,241.8400
1,715,184.6400
Diluted Average Shares
1,673,137.2500
1,695,194.0000
1,653,674.0000
1,719,936.4000
1,719,560.9600
Total Operating Income as Reported
--
2,080,489.0000
1,839,324.0000
--
--
Total Expenses
35,385,827.0000
32,020,446.0000
27,225,453.0000
22,752,504.0000
19,127,850.0000
Net Income from Continuing & Discontinued Operation
1,110,303.0000
1,054,973.0000
996,112.0000
751,934.0000
484,444.0000
Normalized Income
1,077,960.9481
952,015.9385
991,025.4120
757,273.8260
496,615.7560
Interest Income
27.0000
43.0000
487.0000
64.0000
--
Interest Expense
818,495.0000
737,787.0000
559,223.0000
316,003.0000
283,372.0000
Net Interest Income
-972,537.0000
-916,576.0000
-673,914.0000
-388,723.0000
-304,939.0000
EBIT
2,250,491.0000
1,954,480.0000
1,752,432.0000
1,303,265.0000
899,740.0000
EBITDA
3,152,340.0000
2,752,170.0000
2,452,598.0000
2,630,375.0000
2,077,022.0000
Reconciled Cost of Revenue
26,453,573.0000
23,766,426.0000
20,257,912.0000
16,920,834.0000
14,175,708.0000
Reconciled Depreciation
901,849.0000
797,690.0000
700,166.0000
1,327,110.0000
1,177,282.0000
Net Income from Continuing Operation Net Minority Interest
1,110,303.0000
1,054,973.0000
996,112.0000
751,934.0000
484,444.0000
Total Unusual Items Excluding Goodwill
40,656.0000
148,929.0000
5,980.0000
-6,899.0000
-15,139.0000
Total Unusual Items
70,767.0000
179,040.0000
5,980.0000
-6,899.0000
-15,139.0000
Normalized EBITDA
3,081,573.0000
2,573,130.0000
2,446,618.0000
2,637,274.0000
2,092,161.0000
Tax Rate for Calcs
0.0002
0.0001
0.0001
0.0002
0.0002
Tax Effect of Unusual Items
8,313.9481
15,860.9385
893.4120
-1,559.1740
-2,967.2440
12/31/2020 - 7/19/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade